Table 1.
Patient Characteristics at Baseline.a
| Patient characteristics | Control group (n = 100) | Intervention (MDMPS) group (n = 100) | P-value | |
|---|---|---|---|---|
| Median age (IQR) | 77.5 (68.5-82.0) | 77.5 (69.0-82.0) | .951 | |
| Gender | Number of female patients | 59 | 59 | 1.000 |
| Number of male patients | 41 | 41 | ||
| Race | Number of Chinese patients | 81 | 81 | 1.000 |
| Number of non-Chinese patients | 19 | 19 | ||
| Number of patients with HTN | 100 | 100 | 1.000 | |
| Number of patients with HLD | 100 | 100 | 1.000 | |
| DM status | Number of patients without DM | 11 | 11 | 1.000 |
| Number of patients with DM | 89 | 89 | ||
| Use of insulin | Number of DM patients not on insulin | 69 | 69 | 1.000 |
| Number of DM patients on insulin | 20 | 20 | ||
| LDL-C b (mmol/L) | Number of patients with LDL-C <2.6 | 66 | 69 | .725 |
| Number of patients with LDL-C ≥2.6 | 33 | 31 | ||
| Median LDL-C (IQR) | 2.30 (1.9-2.8) | 2.22 (1.8-2.7) | .525 | |
| SBP c (mmHg) | Number of patients with SBP <140 | 52 | 53 | .887 |
| Number of patients with SBP ≥140 | 48 | 47 | ||
| Median SBP (IQR) | 138 (127-149) | 136 (128-150) | .582 | |
| DBP c (mmHg) | Number of patients with DBP <90 | 96 | 94 | .516 |
| Number of patients with DBP ≥90 | 4 | 6 | ||
| Median DBP (IQR) | 70 (62-77) | 70 (64-76) | .955 | |
| HbA1c d in patients with DM (mmol/L) | Number of patients with HbA1c ≤7.0 | 24 | 23 | .931 |
| Number of patients with HbA1c 7.1-9.0 | 48 | 47 | ||
| Number of patients with HbA1c >9.0 | 17 | 19 | ||
| Median HbA1c (IQR) | 7.6 (7.0-8.4) | 8 (7.0-8.7) | .330 | |
| MPR | Number of non-adherent patients | 21 | 21 | 1.000 |
| Number of adherent patients | 79 | 79 | ||
| Median MPR (IQR) | 90.02 (81.06-100.00) | 97.85 (83.46-100.00) | .039** | |
| Median number of chronic medications (IQR) | 7 (6-8) | 7 (6-9) | .041** | |
| Median number of HLD medications (IQR) | 1 (1-1) | 1 (1-1) | .916 | |
| Median number of HTN medications (IQR) | 2 (1-3) | 2 (2-3) | .189 | |
| Median number of OHGA for DM patients (IQR) | 2 (1-2) | 2 (1-2) | .632 | |
Abbreviations: DBP: diastolic blood pressure; DM: type 2 diabetes mellitus; HbA1c: glycated hemoglobin; HLD: hyperlipidemia; HTN: hypertension; LDL-C: low-density lipoprotein-cholesterol; MPR: medication possession ratio; OHGA: oral hypoglycemic agents; SBP: systolic blood pressure.
a
Data are presented in numbers unless stated otherwise.
b
Optimal LDL-C levels are less than 2.6 mmol/L in patients with HLD as per Adult Treatment Panel (ATP III) guidelines.9
c
Target SBP of less than 140 mmHg and target DBP of less than 90 mmHg in hypertensive patients as per Joint National Committee (JNC 8) guidelines.10
d
HbA1c of less than 7% in DM patients as per American Diabetes Association (ADA 2018) guidelines.11
**
P < .05.